Post Marketing Surveillance Study To Observe Safety And Efficacy Of Toviaz (Registered)
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2016
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 22 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Apr 2009 New trial record